A study of carbapenemase-producing organisms found similar rates of infections, highlighting treatment challenges, the role of rapid diagnostics, and surveillance on antimicrobial stewardship due to high mortality rates.
Kirby An, PharmD
Advertisement
PGY-2 Infectious Disease Pharmacy Resident at Northwell - Long Island Jewish Medical Center/North Shore University Hospital.
Articles by Kirby An, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
5
